Details
- Organisation Name: Coral Sea Clinical Research Institute
- HHS: N/A
- Services Offered: Clinical trials site, Investigator Initiated Trials, Completion of study documentation as per ICH GCP and contract
- Website Address: www.coralseaclinical.com
- Contact: Elizabeth Gibson- elizabeth@coralseaclinical.com
- Other Affiliated Research Sites: No
Location
-21.1276,149.1658
Initiating study activities approval
No
Review required
2 weeks
Site Overview
Coral Sea Clinical Research Institute is a clinical research facility in Northern Queensland. Specialising in Phase II and III Gastroenterology trials, Coral Sea Clinical Research Institute work alongside a team of leading, internationally recognised Gastroenterologists to deliver high quality clinical trials.
CSCRI conducts all trials in alignment with ICH Good Clinical Practice and in accordance with local, national and international guidelines and regulatory bodies (Declaration of Helsinki, TGA (Australia), FDA (USA), National Health and Medical Research Council (NHMRC) and Medicines Australia).
CSCRI conducts all trials in alignment with ICH Good Clinical Practice and in accordance with local, national and international guidelines and regulatory bodies (Declaration of Helsinki, TGA (Australia), FDA (USA), National Health and Medical Research Council (NHMRC) and Medicines Australia).
HREC
- HREC Committee Name: Bellberry Human Research Ethics Committee
- Meeting frequency: Twice a Month
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Local
- Mandate distribution of safety: No
- Meeting frequency: Twice a Month
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Local
- Mandate distribution of safety: No
Facility staffing and training
- Handling Investigational Product: Yes
- Training program for the research staff: Yes
- Include GCP: Yes
- Facility written sop during transportation to satellite site: N/A
- Training program for the research staff: Yes
- Include GCP: Yes
- Facility written sop during transportation to satellite site: N/A
Licenses to receive, store, dispense and return controlled substances
- Required Licenses or Registrations: Not Applicable
- Does the Facility have the ability to handle radio-labelled Investigational Products? No
- Does the Facility have the ability to handle radio-labelled Investigational Products? No
Equipment
- Investigational Product: Horizontal laminar flow hood (non-hazardous drug preparation)
- Centrifuge: Yes
- Refrigerated Centrifuge: Yes
- Centrifuge: Yes
- Refrigerated Centrifuge: Yes
Patient Records
- Record Archiving: Yes
- EMR/EHR systems: In-house system
- Has your Clinical Trial Site or Service been accredited? No
- Audit Type: N/A
- EMR/EHR systems: In-house system
- Has your Clinical Trial Site or Service been accredited? No
- Audit Type: N/A
Investigational product storage Capabilities
- Refrigerator (2 to 8 Degrees C): Yes
- Freezer (-20 to -30 Degrees C): Yes
- Investigational Freezer (-70 to -80 Degrees C): Yes
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? No
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
- Freezer (-20 to -30 Degrees C): Yes
- Investigational Freezer (-70 to -80 Degrees C): Yes
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? No
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
Specialty Research Area
Crohn's Disease
Gastroenterology
Immune System Diseases
Inflammatory Bowel
Inflammatory Bowel Diseases
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS)
Metabolic Diseases
Neuroscience
Nutrition
Nutritional and Metabolic Diseases
Ulcerative Colitis
Study Types
Industry
Investigator
Source Document Types
Paper and Electronic
Average time to start study (in calendar days)
30-60
How long prior to HREC meeting does the application need to be submitted?
2 weeks
Support in-patient admissions
No
PK & PD specimens
Yes
Study Phase Capability
Device Pilot
Device Pivotal
Device Post Approval
Phase I
Phase II
Phase III
Phase IV
Patient Population
Adults - Ages 18-64
Pediatrics - Less than or equal to 17